Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Merck Serono brings electronic MS device to six more countries

RebiSmart works alongside the company's MSdialog web-based software
RebiSmart_Merck_Serono

Merck Serono has launched its RebiSmart self-injection device for patients with multiple sclerosis (MS) in six more countries.

The device will now be available in Spain, Greece, Hungary, Israel, Chile and Colombia, following initial launches in 14 countries in May.

Dr Steven Hildemann, chief medical officer and head of global medical affairs and global drug safety at Merck Serono, said: “With the introduction of MSdialog, we are offering a unique digital technology to provide people with MS a management system that can help them create a more open dialogue with their healthcare team.

After using the device to inject themselves RebiSmart is docked and wirelessly send treatment data such as injection times and doses to the MSdialog server.

The MSdialog system can also be used to prompt patients, via email or text message reminders, to take their medication and it periodically sends out health report questionnaires for patients to answer.

Merck's original RebiSmart was the first injection device in MS to record the date, time and dosage of injections to help healthcare professionals monitor patient adherence.

The device was first launched in countries including Germany, France, the UK and Sweden in May and Merck Serono will continue rolling it out during 2015.

19th November 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics